Deficiency of Tfh Cells and Germinal Center in Deceased COVID-19 Patients

Springer Science and Business Media LLC - 2020
Ya qi Duan1, Ming hui Xia2, Liang Ren3, Yan fang Zhang4, Qi lin Ao1, San peng Xu1, Dong Kuang1, Qian Liu3, Bing Yan4, Yi Zhou3, Qian Chu5, Liang Liu3, Yang Xiang2, Guo ping Wang6
1Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
2Department of Immunology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
3Department of Forensic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China
4State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China
5Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
6Department of Pathology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020,395:497–506

Puelles VG, Lütgehetmann M, Lindenmeyer MT, et al. Multiorgan and Renal Tropism of SARS-CoV-2. N Engl J Med, 2020, NEJMc2011400

Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature, 2003,426:450–4

Shang J, Ye G, Shi K, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature, 2020,581:221–224

Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Jama, 2020,323:1061–9

Xu X, Han M, Li T, et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A, 2020,117:10970–10975

Giamarellos-Bourboulis EJ, Netea MG, Rovina N, et al. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Cell Host Microbe, 2020,27:992–1000.e3

Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med, 2020,8:420–422

Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis, 2020, ciaa248

Mesin L, Ersching J, Victora GD. Germinal Center B Cell Dynamics. Immunity, 2016,45:471–482

Cyster JG and Allen CDC. B Cell Responses: Cell Interaction Dynamics and Decisions. Cell, 2019,177:524–540

Thevarajan I, Nguyen THO, Koutsakos M, et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med, 2020,26:453–455

Ni L, Ye F, Cheng ML, et al. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals. Immunity, 2020,52(6):971–977.e3

Cao Y, Su B, Guo X, et al. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients’ B cells. Cell, 2020,182(1):73–84.e16

Diao B, Wang C, Tan Y, et al. Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19). Front Immunol, 2020,11:827

Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduc Target Ther, 2020,5(1):33

Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest, 2020,130:2620–2629

Crotty S. Follicular Helper CD4 T Cells (TFH). Annu Rev Immunol, 2011,29:621–663

Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell, 2020,181(7):1489–1501.e15

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Thông tin tác giả